Clinical Trial Update: Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluated the efficacy and safety of oral bosentan in patients with idiopathic pulmonary fibrosis. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: Actelion | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2, Phase 3 | Status: COMPLETED